Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...

TG Therapeutics is entering 2025 with investors accustomed to a beat-and-raise guidance policy and the company needs to ...

Outlook Therapeutics (OTLK) announced the presentation of data from NORSE EIGHT at the Hawaiian Eye and Retina 2025 Meeting being held January ...

ST. CHARLES, MI — A Sanilac County woman is accused of fraudulently buying several crossbows from a St. Charles sporting goods store then trying to sell them at a Flint pawn shop. Kimberly A.

We list the best free presentation software, to make it simple and easy to create professional presentations without a subscription to Microsoft PowerPoint. While PowerPoint is the market leader ...

In years past, crossbow manufacturers focused on increasing bolt speed while minimizing costs. Though speed is still a focal point for new crossbows, a few other trends emerged in 2025.

SEATTLE, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a ...

A live webcast of the Company’s presentation may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website. Dianthus Therapeutics is a clinical-stage ...

ZUG, Switzerland and BOSTON – CRISPR Therapeutics (NASDAQ:CRSP), a leader in gene-based medicine development, announced today its intention to appoint Briggs Morrison, M.D., to its Board of Directors ...